| Novo Nordisk Pharma AG - Ryzodeg Penfill, Injektionslösung |
| 62627 | | 01 | | Ryzodeg Penfill | | Injektionslösung | | A10AD06 | | Insulin Degludec and Insulin Aspart | | 12.09.2013 | | |
|
| Composition |
| insulinum degludecum 420 nmol corresp. insulinum degludecum 70 U., insulinum aspartum 180 nmol corresp. insulinum aspartum 30 U., glycerolum, natrii chloridum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Insuline Aspart | 180 | | Insulinum Degludecum | 420 | | Nmol | |
| | BAG: Principe actif | Concentr. |
|---|
| Insulinum Analogum | 100 U | | Insuline Aspart | 30 U | | Insulinum Degludecum | 70 U |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Glycerol | | | | Metacresol | 1.72 mg/ml | | | Sodium Chlorure | | | | Phenol | 1.5 mg/ml | conserv. | | Zincum | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 x 3 ml | 67.56 | 89.90 | B | LS | Non |
|
